ULTRA LONG PULSE SELECTIVE PHOTOTHERMOLYSIS LASER

Information

  • Research Project
  • 3502213
  • ApplicationId
    3502213
  • Core Project Number
    R43HL048388
  • Full Project Number
    1R43HL048388-01
  • Serial Number
    48388
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/1/1992 - 31 years ago
  • Project End Date
    1/31/1993 - 31 years ago
  • Program Officer Name
  • Budget Start Date
    8/1/1992 - 31 years ago
  • Budget End Date
    1/31/1993 - 31 years ago
  • Fiscal Year
    1992
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/22/1992 - 31 years ago
Organizations

ULTRA LONG PULSE SELECTIVE PHOTOTHERMOLYSIS LASER

DESCRIPTION (Adapted from applicant's abstract):The selective photothermolysis, SPT, model to explain light and tissue interaction was first publicly proposed in 1983. The model illustrates the important role of selective absorption and thermal diffusion and has led to an understanding of how clinical protocols using laser radiation should be designed to optimize therapy. SPT concepts have been used to develop clinical protocols for the treatment of abnormal vascular and pigmented lesions and tattoos. Commercial devices built to use these protocols have gained market acceptance. Laser hardware needs further improvement because state-of-the-art devices do not produce the optimum pulse durations for the treatment of ectatic vascular lesions. Pulse durations from commercial dye lasers used for the treatment of port wine stain birthmarks are limited to 400 microseconds. The SPT model requires pulse durations closer to 4 milliseconds for the optimized treatment of 100 micron diameter vessels or larger. All clinical indications show that longer pulses fitting the needs of SPT would greatly improve clinical end points and better treat larger vessels. It is believed that longer pulses will help in the treatment of telangiectasia of the lower limbs, the leg vein problem which is reputed to have a large commercial significance.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    CYNOSURE, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CHELMSFORD
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01824
  • Organization District
    UNITED STATES